Andrea Cavazzoni

University of Parma — Italy

Medicine · Health Sciences

37h-index3.2kcitations117works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(41), PI3K/AKT/mTOR signaling in cancer(20), HER2/EGFR in Cancer Research(19), Advanced Breast Cancer Therapies(13), Cancer-related Molecular Pathways(11)

Publications116 total

Target validation of natural compounds: Perillaldehyde case study
International Immunopharmacology·2026
Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling
Breast Cancer Research and Treatment·2026Open Access
Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer
Cancer Drug Resistance·2025Open Access
Abstract 6569: Extracellular vesicle delivery of functional extrachromosomal DNA in FGFR2-amplified cancer of unknown primary
Cancer Research·2025
Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
Journal of Experimental & Clinical Cancer Research·2025· 1 citedOpen Access
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666
Cancers·2025Open Access
Extracellular vesicles deliver functional extrachromosomal DNA in FGFR2-amplified cancer of unknown primary
2025Open Access
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Frontiers in Oncology·2024Open Access
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
Molecular Therapy·2024· 4 citedOpen Access
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments
Biochemical Pharmacology·2024· 9 citedOpen Access
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines
Biochemical Pharmacology·2024· 11 citedOpen Access
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
Scientific Reports·2024· 9 citedOpen Access
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
Lung Cancer·2023· 18 citedOpen Access
Role of Cytokines and Other Soluble Factors in Tumor Development: Rationale for New Therapeutic Strategies
Cells·2023· 13 citedOpen Access
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators
Targeted Oncology·2023· 8 citedOpen Access
P-27 Circulating neural growth factor in pancreatic cancer adenocarcinoma
Annals of Oncology·2023Open Access
Data from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Data from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Tables S1-S5 from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
Supplementary Materials and Methods from Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring <i>PIK3CA</i> Gene Alterations
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Roberta Alfieri(43), Pier Giorgio Petronini(40), Mara Bonelli(31), Claudia Fumarola(30), Silvia La Monica(27), Maricla Galetti(25), Marcello Tiseo(23), Daniele Cretella(21), Andrea Ardizzoni(20), Graziana Digiacomo(13), Federico Quaini(9), Marco Mor(9), Elisa Giovannetti(8), Daniele Generali(7), Denise Madeddu(7), Elena Galvani(7), Cristina Caffarra(7), Elisabetta Barocelli(6), Caterina Carmi(6), Alessio Lodola(6)